CD8A and hepatocellular carcinoma: For bile acid modulation, polyoxazolines-based nanocarriers deliver obeticholic acid to regulate hepatic bile acid balance, reducing immunosuppressive TCA and enhancing intrahepatic CD8+ T cell infiltration in HCC (327).